Search - tctmd.com

Displaying 181 - 200 of 473

Sort: Relevancy | Date

News Daily News

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

September 11, 2014

News Daily News

Observational Study Affirms Higher Kidney Injury Risk After CABG vs PCI

Todd Neale

September 11, 2014

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Industry News

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

September 09, 2014

News Daily News

MitraClip Repair Safe, Effective for MR in Large European Registry

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Daily News

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Conference News ESC 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Todd Neale

August 31, 2014

News Conference News ESC 2014

Observational Studies Ask How Much Medication Adherence Matters After MI

Caitlin E. Cox

August 31, 2014

News Industry News

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

August 31, 2014

News Industry News

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

August 30, 2014

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

News Industry News

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

August 07, 2014

Advertisement

不完全的血运重建与患CAD的TAVR患者的较差结果有联系

Observational Study Affirms Higher Kidney Injury Risk After CABG vs PCI

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

European Societies Release Updated Revascularization Guidelines for CAD

Thoratec Announces Start Of Heartmate III™ U.S. Clinical Trial

MitraClip Repair Safe, Effective for MR in Large European Registry

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Observational Studies Ask How Much Medication Adherence Matters After MI

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content